These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29395846)

  • 1. Thymopoiesis following HSCT; a retrospective review comparing interventions for aGVHD in a pediatric cohort.
    Flinn AM; Roberts CF; Slatter MA; Skinner R; Robson H; Lawrence J; Guest J; Gennery AR
    Clin Immunol; 2018 Aug; 193():33-37. PubMed ID: 29395846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymopoiesis, Alterations in Dendritic Cells and Tregs, and Reduced T Cell Activation in Successful Extracorporeal Photopheresis Treatment of GVHD.
    Flinn AM; Ehrlich A; Roberts C; Wang XN; Chou J; Gennery AR
    J Clin Immunol; 2021 Jul; 41(5):1016-1030. PubMed ID: 33651234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience.
    Calore E; Marson P; Pillon M; Tumino M; Tison T; Mainardi C; De Silvestro G; Rossin S; Franceschetto G; Carraro E; Pescarin M; Varotto S; Destro R; Gazzola MV; Basso G; Messina C
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1963-72. PubMed ID: 26183078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation.
    Weinberg K; Blazar BR; Wagner JE; Agura E; Hill BJ; Smogorzewska M; Koup RA; Betts MR; Collins RH; Douek DC
    Blood; 2001 Mar; 97(5):1458-66. PubMed ID: 11222394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
    Weitz M; Strahm B; Meerpohl JJ; Bassler D
    Cochrane Database Syst Rev; 2014 Feb; (2):CD009759. PubMed ID: 24569960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Ussowicz M; Musiał J; Mielcarek M; Tomaszewska A; Nasiłowska-Adamska B; Kałwak K; Gorczyńska E; Mariańska B; Chybicka A
    Transplant Proc; 2013 Nov; 45(9):3375-80. PubMed ID: 24182819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report.
    Berger M; Pessolano R; Albiani R; Asaftei S; Barat V; Carraro F; Biasin E; Madon E; Fagioli F
    J Pediatr Hematol Oncol; 2007 Oct; 29(10):678-87. PubMed ID: 17921848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation.
    Clave E; Busson M; Douay C; Peffault de Latour R; Berrou J; Rabian C; Carmagnat M; Rocha V; Charron D; Socié G; Toubert A
    Blood; 2009 Jun; 113(25):6477-84. PubMed ID: 19258596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracoporeal photopheresis treatment of acute graft-versus-host disease following allogeneic haematopoietic stem cell transplantation.
    Flinn AM; Gennery AR
    F1000Res; 2016; 5():. PubMed ID: 27408705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
    Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
    Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study.
    Berger M; Albiani R; Sini B; Fagioli F
    Transfusion; 2015 Apr; 55(4):736-47. PubMed ID: 25355659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis.
    Jagasia M; Greinix H; Robin M; Das-Gupta E; Jacobs R; Savani BN; Engelhardt BG; Kassim A; Worel N; Knobler R; Russell N; Socie G
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1129-33. PubMed ID: 23623892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of extracorporeal photopheresis in pediatric patients with graft-versus-host disease after hematopoietic stem cell transplantation.
    Winther-Jørgensen S; Nygaard M; Heilmann C; Ifversen M; Sørensen K; Müller K; Masmas T
    Pediatr Transplant; 2019 Jun; 23(4):e13416. PubMed ID: 30973668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.
    Buder K; Zirngibl M; Bapistella S; Meerpohl JJ; Strahm B; Bassler D; Weitz M
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD009759. PubMed ID: 36166494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: A multicenter experience.
    Batgi H; Dal MS; Erkurt MA; Kuku I; Kurtoglu E; Hindilerden IY; Kaya E; Berber I; Ulas T; Altuntas F
    Transfus Apher Sci; 2021 Oct; 60(5):103242. PubMed ID: 34420882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal photopheresis as first-line strategy in the treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: A single-center experience.
    Sestili S; Eder S; Belhocine R; Dulery R; Battipaglia G; Brissot E; Mediavilla C; Banet A; van de Wyngaert Z; Paviglianiti A; Ledraa T; Bonin A; Mohty M; Malard F
    Cytotherapy; 2020 Aug; 22(8):445-449. PubMed ID: 32434750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
    Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
    Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal photopheresis (ECP) improves overall survival in the treatment of steroid refractory acute graft-versus-host disease (SR aGvHD).
    Solh MM; Farnham C; Solomon SR; Bashey A; Morris LE; Holland HK; Zhang X
    Bone Marrow Transplant; 2023 Feb; 58(2):168-174. PubMed ID: 36352015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective Multicenter Study of Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic Graft-versus-Host Disease.
    Oarbeascoa G; Lozano ML; Guerra LM; Amunarriz C; Saavedra CA; Garcia-Gala JM; Viejo A; Revilla N; Acosta Fleitas C; Arroyo JL; Martinez Revuelta E; Galego A; Hernandez-Maraver D; Kwon M; Diez-Martin JL; Pascual C;
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):651-658. PubMed ID: 31917270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
    Weitz M; Strahm B; Meerpohl JJ; Schmidt M; Bassler D
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009759. PubMed ID: 26666580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.